- e-SPACE CRM
- About TMA
- Mission Areas
- Case Stories
Click here to access VOD
THE FIRST GLOBAL WEB-CONFERENCE
SYNDROME: e-SPACE CRM
2021: TMA launches a holistic and multidisciplinary Gene therapy educational initiative
Gene Therapy is a fast growing field with therapeutic options already available for clinicians and patients. A review of ongoing clinical trials shows the extreme dynamism of clinical research. Around 200 clinical trials are ongoing in almost 80 diseases. The therapeutic applications encompass almost all medical fields. Gene therapy has the potential to revolutionize different cancer therapies. The correction of severe metabolic or hematologic inherited diseases are offering new hopes to help patients suffering from debilitating diseases. In Onco-hematology the CAR-T cells are also bringing new hopes and several approaches have been implemented in clinical practice. In Duchenne muscular dystrophy, gene editing by Cas9 and gRNAs for exon snipping may offer a path to future development of a clinically applicable therapeutic option. Cardiology, Dermatology, Neurology, Ophthalmology are also explored, hoping to bring innovative solutions for patient care.
Welcome to TMA
Dedicated to understand specific critical medical areas to improve therapeutic approaches, The Translational Medicine Academy (TMA) is an international academic Foundation with focused activies in mission areas of high public health importance having significant professional and patient therapeutic and educational gaps.
Translate the medical research evidence into medical practice. Read more.
HEART FAILURE VIDEOS
Prof Stefan Anker, chair of the Heart Failure guideline forum, shares with us the highlight of the 2018 heart Failure guideline forum in Nice (October 15-16, 2018). Join us for 2019 edition!”